News Center
Lizhu first won the "Golden Bauhinia"
Release time:
2016-11-21
On November 23, Lijun Pharmaceutical Group (000513.SZ, 1513.HK) was awarded the "Most Growth-Oriented Listed Company" at the China Securities Golden Bauhinia Awards. This is the first time the company has won an award in the Hong Kong capital market since it was listed on the Hong Kong main board in January 2014. The sixth "China Securities Golden Bauhinia Awards" presented a total of 11 categories of awards, including "Most Influential Listed Company Leader," "Best Listed Company CEO," "Most Investment Value Listed Company Award," and "Most Growth-Oriented Listed Company Award." As one of the most authoritative selection activities for listed companies in the Chinese capital market,
On November 23, Livzon Pharmaceutical Group (000513.SZ, 1513.HK) was awarded the "Most Growth-Oriented Listed Company" at the China Securities Golden Bauhinia Awards. This is the first time the company has won an award in the Hong Kong capital market since its listing on the Hong Kong main board in January 2014.
The sixth "China Securities Golden Bauhinia Awards" presented 11 categories of awards, including "Most Influential Listed Company Leader," "Best Listed Company CEO," "Most Investment Value Listed Company Award," and "Most Growth-Oriented Listed Company Award."
As one of the most authoritative selection activities for listed companies in the Chinese capital market, the China Securities "Golden Bauhinia" Award has reached its sixth year this year. The award is a professional selection for all listed companies and their executives in mainland China and Hong Kong. It is jointly organized by the Hong Kong Ta Kung Wen Wei Media Group, the Hong Kong Chartered Secretaries Association, the Hong Kong Chinese Enterprises Association, the Hong Kong Chinese Securities Association, the Hong Kong Chinese Financial Association, the Hong Kong Securities Institute, and other seven organizations. Since its establishment, the event has received high praise from the industry multiple times.
Mr. Yang Liang, Secretary of the Board of Directors of Livzon Pharmaceutical Group, attended the award ceremony and went on stage to receive the award.
For a long time, Livzon has focused on the field of life and health, having received numerous honors, and it can be said that the company has made positive contributions to human life and health. Especially in the past three years, Livzon has entered a fast track of development: the company has relocated to the Livzon Industrial Park, which has leading domestic and world-class hardware facilities, and is transforming towards a biopharmaceutical strategy. This award of "Golden Bauhinia" in Hong Kong is well-deserved and fully reflects the increasing attention the company receives from domestic and foreign investors in the capital market.
Related Information